Literature DB >> 3050940

Neurological complications of human immunodeficiency virus infection.

P G Kennedy1.   

Abstract

The protean neurological manifestations of human immunodeficiency virus (HIV) infection are reviewed. Both the central nervous system and peripheral nervous system may be affected and many of the complications may occur in individuals with acquired immunodeficiency syndrome (AIDS)-related complex, or who are seropositive for HIV alone as well as those with the established AIDS syndrome. Specific therapy is available for certain of these neurological conditions, but the clinical course in others is untreatable and progressive. Although it seems likely that the pathogenesis of some of these syndromes such as the AIDS-dementia complex are due to the direct effect of HIV on the nervous system, in others the neurological injury probably occurs as a consequence of the immunosuppression which HIV induces, or immune-mediated mechanisms.

Entities:  

Mesh:

Year:  1988        PMID: 3050940      PMCID: PMC2428834          DOI: 10.1136/pgmj.64.749.180

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  39 in total

1.  JC Papovavirus in progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; A E Hodach; S M Chou
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

2.  Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy.

Authors:  K H Rand; K P Johnson; L J Rubinstein; J S Wolinsky; J B Penney; D L Walker; B L Padgett; T C Merigan
Journal:  Ann Neurol       Date:  1977-05       Impact factor: 10.422

3.  A subcutaneous reservoir for intrathecal therapy of fungal meningitis.

Authors:  R D Diamond; J E Bennett
Journal:  N Engl J Med       Date:  1973-01-25       Impact factor: 91.245

Review 4.  Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy).

Authors:  G M Zu Rhein
Journal:  Prog Med Virol       Date:  1969

5.  Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid.

Authors:  R M Snow; W E Dismukes
Journal:  Arch Intern Med       Date:  1975-09

6.  Spectrum of central nervous system complications in homosexual men with acquired immune deficiency syndrome.

Authors:  S D Pitlik; V Fainstein; R Bolivar; L Guarda; A Rios; P A Mansell; F Gyorkey
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

7.  Evaluation of cerebral mass lesions in acquired immunodeficiency syndrome.

Authors:  A E Pitchenik; M A Fischl; K W Walls
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

8.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

View more
  8 in total

1.  The widening spectrum of infectious neurological disease.

Authors:  P G Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

2.  Idiopathic granulomatous meningitis.

Authors:  A M Bakheit; P G Kennedy; D I Graham; J R More
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

Review 3.  SIV Latency in Macrophages in the CNS.

Authors:  Lucio Gama; Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Kelly A Metcalf Pate; Brandon T Bullock; M Christine Zink; Joseph L Mankowski; Janice E Clements
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

4.  Brain macrophages harbor latent, infectious simian immunodeficiency virus.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

5.  A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.

Authors:  Thomas D Marcotte; Reena Deutsch; Benedict Daniel Michael; Donald Franklin; Debra Rosario Cookson; Ajay R Bharti; Igor Grant; Scott L Letendre
Journal:  J Neuroimmune Pharmacol       Date:  2013-10-08       Impact factor: 4.147

Review 6.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

Review 7.  A Quantitative Approach to SIV Functional Latency in Brain Macrophages.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-30       Impact factor: 7.285

8.  Tumour necrosis factor-alpha mediates blood-brain barrier damage in HIV-1 infection of the central nervous system.

Authors:  M K Sharief; M Ciardi; E J Thompson; F Sorice; F Rossi; V Vullo; A Cirelli
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.